-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Baiyunshan (600332.SH) issued an announcement. Recently, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. (“Tianxin Pharmaceutical”), a holding subsidiary of the company, received the “Drug Supplement Application Approval Notice” approved and issued by the State Drug Administration. Amikacin sulfate injection (2ml: 0.2g) (200,000 units) has passed the consistent evaluation of the quality and efficacy of generic drugs.

智通財經·10/15/2026 08:25:09
語音播報
Zhitong Finance App News, Baiyunshan (600332.SH) issued an announcement. Recently, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. (“Tianxin Pharmaceutical”), a holding subsidiary of the company, received the “Drug Supplement Application Approval Notice” approved and issued by the State Drug Administration. Amikacin sulfate injection (2ml: 0.2g) (200,000 units) has passed the consistent evaluation of the quality and efficacy of generic drugs.